AbbVie Is a Stock to Position for 2021

Let's review the charts and indicators.

McKesson's Charts Still Look Bullish

Let's review the charts and indicators.

The Correction in AstraZeneca Could Be Nearing an End

Aggressive traders might want to look past any near-term price weakness and consider a small long position.

Concert Pharmaceuticals Could Rally in 2021

Let's review the charts and indicators.

Acceleron Pharma Looks Poised to Continue Bull Run in 2021

The biopharma company's stock has built a nice base, which suggests the shares could keep moving significantly higher in the coming months.

I Like Peloton to Keep Rolling in 2021, and Planet Fitness Might Be a Buy, Too

The former name is technically overbought but offers reasons to expect it to grow, while the latter should benefit from the Covid-19 vaccines.

Let's Put COMPASS Pathways in the Watch but Not Act Yet Category

CMPS may be a company representing the true cannabis 2.0. The irony in that is it isn't a cannabis company but rather a play on psilocybin.

A Technical Update on Halozyme Therapeutics

Let's review the charts and indicators.

McKesson's Rally Has Further to Go

The shares have been digesting and consolidating the gains achieved in early November.

What the Charts Say About Veeva Systems Stock

Our latest analysis and trading strategy for the cloud healthcare software provider.